Cost per beneficiary of select drugs in Canada's public drug plans 2021/2022

Published by
Matej Mikulic,
Feb 7, 2024

As of fiscal year 2021/2022, prescription drug Trikafta (elexacaftor/tezacaftor/ivacaftor) cost on average some 89 thousand Canadian dollars per beneficiary. Trikafta is a medicine used to treat cystic fibrosis.

Average cost per beneficiary of select prominent drugs in Canada's public drug plans in 2021/2022 (in Canadian dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

2023

Region

Canada

Survey time period

FY 2021/2022

Supplementary notes

The public drug plans include British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador, and Yukon.
This analysis only includes data for beneficiaries that met their deductible and received public reimbursement.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Canadian pharmaceutical industry "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Canadian pharmaceutical industry

Global positioning

4

Key figures

6

Regional comparison

4

Products and prices

6

Therapy classes

4

Generics

6

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in CanadaGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPharmaceutical research and development (R&D)
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu